AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 142 filers reported holding AMICUS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,621,000 | -32.8% | 527,430 | +0.0% | 0.00% | -40.0% |
| Q3 2016 | $3,903,000 | +51.5% | 527,392 | +11.7% | 0.01% | +66.7% |
| Q2 2016 | $2,577,000 | -23.0% | 472,055 | +19.1% | 0.00% | -25.0% |
| Q1 2016 | $3,348,000 | -11.5% | 396,235 | +1.6% | 0.00% | -20.0% |
| Q4 2015 | $3,785,000 | -30.3% | 390,174 | +0.5% | 0.01% | -28.6% |
| Q3 2015 | $5,432,000 | +17.3% | 388,287 | +18.6% | 0.01% | +16.7% |
| Q2 2015 | $4,632,000 | +3963.2% | 327,335 | +3030.6% | 0.01% | – |
| Q1 2015 | $114,000 | +32.6% | 10,456 | +1.3% | 0.00% | – |
| Q4 2014 | $86,000 | +68.6% | 10,320 | +19.5% | 0.00% | – |
| Q3 2014 | $51,000 | +121.7% | 8,636 | +25.8% | 0.00% | – |
| Q2 2014 | $23,000 | -87.3% | 6,864 | -92.2% | 0.00% | – |
| Q1 2014 | $181,000 | -13.4% | 87,527 | -1.4% | 0.00% | – |
| Q4 2013 | $209,000 | +2.0% | 88,750 | +0.5% | 0.00% | – |
| Q3 2013 | $205,000 | +3.5% | 88,313 | +3.7% | 0.00% | – |
| Q2 2013 | $198,000 | – | 85,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |